Literature DB >> 11808787

Oral intake of Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1 prevents collagen-induced arthritis in mice.

Hiroshi Kano1, Tsutomu Kaneko, Shuichi Kaminogawa.   

Abstract

Oral intake of some lactic acid bacteria can have beneficial effects on the host by activating immune responses and enhancing resistance to infection by pathogens. In this study, effects of Lactobacillus sp. on the development of autoimmune disease were examined in mice with collagen-induced arthritis (CIA). CIA, a model of some types of rheumatoid arthritis (RA), can be induced in DBA/1J mice by immunizing them with bovine type II collagen (bCII). Oral intake of skimmed milk (SM) fermented with Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1 (SM/OLL1073R-1) was found to markedly inhibit the development of CIA in these mice, compared with a control group fed the control foodstuff. The inhibitory effect of SM fermented with L. delbrueckii subsp. bulgaricus OLLI 102 (SM/OLL1102) or fresh SM was weaker than that of SM/ OLL1073R-1. A deMan Rogosa Sharpe (MRS) broth culture of OLL1073R-1 without any major components of SM had the same inhibitory effect as SM/OLL1073R-1, suggesting that the inhibitory effect of SM/OLL1073R-1 is attributable not only to SM components but also to OLL1073R-1 cells, their metabolites, or both. We found that SM/OLL1073R-1 and SM caused reduced secretion of the cytokine IFN-gamma by lymph node cells (LNCs) in response to bCII. However, SM/OLL1102 did not affect the secretion of IFN-gamma. A polysaccharide fraction secreted by OLL1073R-1 also exhibited the inhibitory effects on both development of CIA and secretion of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11808787     DOI: 10.4315/0362-028x-65.1.153

Source DB:  PubMed          Journal:  J Food Prot        ISSN: 0362-028X            Impact factor:   2.077


  16 in total

1.  Oral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects.

Authors:  Marco Antonio Moro-García; Rebeca Alonso-Arias; Maria Baltadjieva; Carlos Fernández Benítez; Manuel Amadeo Fernández Barrial; Enrique Díaz Ruisánchez; Ricardo Alonso Santos; Magdalena Alvarez Sánchez; Juan Saavedra Miján; Carlos López-Larrea
Journal:  Age (Dordr)       Date:  2012-05-30

2.  Faecal microbiome in new-onset juvenile idiopathic arthritis.

Authors:  M V Tejesvi; M Arvonen; S M Kangas; P L Keskitalo; A M Pirttilä; T J Karttunen; P Vähäsalo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-30       Impact factor: 3.267

3.  Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis.

Authors:  Xiaofei Liu; Qinghua Zou; Benhua Zeng; Yongfei Fang; Hong Wei
Journal:  Curr Microbiol       Date:  2013-03-13       Impact factor: 2.188

4.  Treatment of adjuvant-induced arthritis with the combination of methotrexate and probiotic bacteria Escherichia coli O83 (Colinfant).

Authors:  J Rovenský; M Stancíková; K Svík; J Utesený; K Bauerová; J Jurcovicová
Journal:  Folia Microbiol (Praha)       Date:  2009-10-14       Impact factor: 2.099

5.  The effect of milk fermented by yogurt cultures plus Lactobacillus casei DN-114001 on the immune response of subjects under academic examination stress.

Authors:  Ascensión Marcos; Julia Wärnberg; Esther Nova; Sonia Gómez; Alberto Alvarez; Rocío Alvarez; José A Mateos; José M Cobo
Journal:  Eur J Nutr       Date:  2004-07-14       Impact factor: 5.614

6.  Oral administration of milk fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 to DBA/1 mice inhibits secretion of proinflammatory cytokines.

Authors:  Hiroshi Kano; Orie Mogami; Masayuki Uchida
Journal:  Cytotechnology       Date:  2002-11       Impact factor: 2.058

7.  A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis.

Authors:  Maria de Los Angeles Pineda; Sarah Frances Thompson; Kelly Summers; Faye de Leon; Janet Pope; Gregor Reid
Journal:  Med Sci Monit       Date:  2011-06

8.  Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial.

Authors:  David R Mandel; Katy Eichas; Judith Holmes
Journal:  BMC Complement Altern Med       Date:  2010-01-12       Impact factor: 3.659

9.  Oral Lactobacillus Species in Systemic Sclerosis.

Authors:  Daniela Melchiorre; Maria Teresa Ceccherini; Eloisa Romano; Laura Cometi; Khadija El-Aoufy; Silvia Bellando-Randone; Angela Roccotelli; Cosimo Bruni; Alberto Moggi-Pignone; Davide Carboni; Serena Guiducci; Gemma Lepri; Lorenzo Tofani; Giacomo Pietramellara; Marco Matucci-Cerinic
Journal:  Microorganisms       Date:  2021-06-15

10.  The effects of orally administered Bacillus coagulans and inulin on prevention and progression of rheumatoid arthritis in rats.

Authors:  Khadijeh Abhari; Seyed Shahram Shekarforoush; Saeid Hosseinzadeh; Saeid Nazifi; Javad Sajedianfard; Mohammad Hadi Eskandari
Journal:  Food Nutr Res       Date:  2016-07-15       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.